Table 2

Characteristics in patients with ischaemic stroke/systemic embolism

Patient no.Age, yearsSexCHADS2 scoreAntithrombotic therapyPrior documented
AF
AHREs detected during follow-upProgression to persistent AFAHREs detected
≤30 days before ischaemic stroke/SE
169F2ASA
273M3None
378M2None
482F3ASA
587F4None
675F3ASA+
775F3ASA+
876F2None++
983M3None+
1084F3ASA++
1187F6None+
1267M5ASA+++
1379F4OAC/ASA+++
1476M3OAC++++
1577M4None++++
1680F5OAC/ASA++++
1782F3OAC/ASA++++
1883M5ASA++++
1987F3None++++
  • AF, atrial fibrillation; AHREs, atrial high rate episodes; ASA, aspirin; F, female; M, male; OAC, oral anticoagulant; SE, systemic embolism.